- Medical cannabis company Creso Pharma (CPH) is one of the top gainers on the ASX today with shares up 27.7 per cent
- It comes as the company's Canadian subsidiary Mernova secured three significant bulk purchase orders
- It also received a notice to purchase from the Province of Ontario which is the country's largest recreational marijuana market
- Ongoing developments and speculation surrounding marijuana decriminalisation also seem to be driving the spike
- Further advances include a vote from the U.S House of Representatives to remove cannabis as an illegal substance from the U.S .Controlled Substances Act
- Creso shares are up 27.7 per cent trading at 30 cents each.
Medical cannabis company Creso Pharma (CPH) is one of the top gainers on the ASX today with shares up 27.7 per cent.
The company's Canadian subsidiary Mernova secured three significant bulk purchase orders.
Among the orders is a maiden purchase order from the Yukon Liquor Corporation, making the company one of the few licenced providers for the area.
Mernova's other two orders are from both licensed producer of medical and recreational cannabis the Truro Cannabis Company and Nova Scotia Liquor Corporation.
The three purchase orders totalled C$275,023 (roughly A$288,159).
Read the full article on The Market Herald
